Ross, A., Donachie, P., Sallam, A., Stratton, I., Mohamed, Q., Scanlon, P., . . . Johnston, R. (2013). Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
Chicago Style (17th ed.) CitationRoss, A., P. Donachie, A. Sallam, I. Stratton, Q. Mohamed, P. Scanlon, J. Kirkpatrick, and R. Johnston. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.
MLA引文Ross, A., et al. Which Visual Acuity Measurements Define High-quality Care for Patients with Neovascular Age-related Macular Degeneration Treated with Ranibizumab? 2013.
警告:這些引文格式不一定是100%准確.